Innovative Product Offering Madorra's development of the first non-invasive, non-hormonal medical device for vaginal dryness represents a unique solution in women’s health, opening opportunities to target healthcare providers and clinics seeking hormone-free treatment options.

Target Market Expansion Focusing on postmenopausal women and breast cancer survivors, Madorra is well-positioned to connect with specialized gynecology practices, oncology centers, and women’s health clinics interested in non-pharmaceutical therapies.

Strong Funding Support With a recent $2.3 million SBIR grant from the NIH, Madorra has validated its innovation potential, making it attractive for strategic partnerships and funding opportunities to scale distribution and clinical adoption.

Growing Revenue Potential Estimated revenues between 1 million and 10 million indicate a niche yet emerging market, suggesting significant sales opportunities as awareness and adoption of non-hormonal treatments increase.

Market Differentiation By offering an at-home device that provides immediate and long-term relief, Madorra can appeal to direct-to-consumer channels, health-conscious women, and advocacy groups seeking accessible, non-hormonal solutions for vaginal health issues.